New York State Common Retirement Fund Uni Qure N.V. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$35.98 - $47.66 $169,717 - $224,812	-4,717 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$40.01 - $73.97 $148,357 - $274,280	-3,708 Reduced 44.01%	4,717 $224,000
Q4 2019 Feb 05, 2020	BUY	$37.13 - $74.62 $87,960 - $176,774	2,369 Added 39.12%	8,425 $604,000
Q3 2019 Nov 07, 2019	BUY	$39.36 - $76.8 $43,138 - $84,172	1,096 Added 22.1%	6,056 $238,000
Q1 2019 May 08, 2019	BUY	$27.39 - $68.41 $135,854 - $339,313	4,960 New	4,960 $296,000

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.